What is it about?
Patients with severe COVID-19 often need mechanical ventilation in intensive care, which exposes them to ventilator-associated pneumonia (VAP), a bacterial lung infection acquired while on the ventilator. We studied 586 COVID-19 patients admitted to several Italian intensive care units during the first pandemic wave (February-May 2020). VAP developed in 171 (29%), corresponding to 18 episodes per 1,000 days of ventilation. When samples were available, the most common bacteria were Pseudomonas aeruginosa and Staphylococcus aureus. Almost half of patients with VAP (46%) died within 30 days. Septic shock and acute respiratory distress syndrome at the time of VAP were strongly associated with death.
Featured Image
Photo by Maxim Tolchinskiy on Unsplash
Why is it important?
VAP turned out to be a frequent and serious complication of severe COVID-19. The very high mortality likely reflects the combined effect of the viral disease and the superimposed bacterial infection. These data underline the importance of preventing VAP, obtaining good microbiological samples and treating it promptly in critically ill COVID-19 patients.
Perspectives
In the first pandemic wave, the focus was entirely on the virus, but many patients died of bacterial complications. Contributing to this multicentre study led by Daniele Roberto Giacobbe and Matteo Bassetti helped quantify a problem we were seeing every day in our intensive care units.
Professor Stefano Di Bella
Universita degli Studi di Trieste
Read the Original
This page is a summary of: Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study, Journal of Clinical Medicine, February 2021, MDPI AG,
DOI: 10.3390/jcm10040555.
You can read the full text:
Contributors
The following have contributed to this page







